COMMUNIQUÉS West-GlobeNewswire

-
Capital Senior Living Appoints Kimberly Lody as President and CEO
08/01/2019 -
Rafael Pharmaceuticals Announces Initiation of Patient Enrollment for Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia
08/01/2019 -
Precipio Files Patent for HemeScreen™, its Novel Molecular Assay
08/01/2019 -
Integra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System
08/01/2019 -
T2 Biosystems Reports Granting of Inducement Awards
08/01/2019 -
Canopy Rivers Announces Investment in Technology Driven Data Company Headset
08/01/2019 -
CureVac Announces U.S. Patent Grant for mRNA Vaccination of Infants Against RSV
08/01/2019 -
CLS Signs Agreement with Siemens Healthineers to Secure Optimal Interfacing to the World Leading Portfolio of Magnetom MRI Scanners from Siemens Healthineers
08/01/2019 -
Integra LifeSciences Announces Preliminary Fourth Quarter 2018 Financial Results
08/01/2019 -
MediPharm Labs Signs Large Multi-Year Cannabis Extraction Agreement With TerrAscend Marking Strong Start to 2019
08/01/2019 -
Corrected Financial Calendar 2019
08/01/2019 -
Transactions in relation to share buyback program
08/01/2019 -
Vistin Pharma ASA : Update on Energy Trading business
08/01/2019 -
Immuron Receives $1.19M R&D Tax Concession Refund
08/01/2019 -
Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
08/01/2019 -
Update on Admission
08/01/2019 -
Scheme becomes effective
08/01/2019 -
NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE IL-4/IL-13 KINOID AS AN ALLERGY TREATMENT
08/01/2019 -
NÉOVACS REÇOIT UN FINANCEMENT DE L'ANR - L'AGENCE NATIONALE DE LA RECHERCHE - POUR LE DÉVELOPPEMENT DE L'IL-4/IL-13 KINOÏDE DANS L'ALLERGIE
08/01/2019
Pages